- 0086-21-58386256
[email protected]
- 10:00am to 6:00pm
Sunday Closed
cesium 131 utilizing
- منتوجات جديدة
GammaTile: Comprehensive Review of a Novel Radioactive …
GammaTile is a Food and Drug Administration (FDA)-licensed device consisting of four cesium-131 (Cs-131) radiation-emitting seeds in the collagen tile about the postage stamp size. ... Combining the maximum safe resection and adjuvant radiation is necessary by utilizing permanent intracranial brachytherapy in patients with recurrent, …
WhatsApp: +86 18221755073
- منتوجات جديدة
Cesium-131 brachytherapy for the treatment of brain …
Cesium-131 isotope has a short half-life, delivers 90% of its dose within a month, shortens the time to initiation of systemic therapy compared to iodine-125 or external radiotherapy, and has an excellent radiation safety profile. Further analyses have demonstrated superior cost-effectiveness and quality-of-life improvement ratios of …
WhatsApp: +86 18221755073
- منتوجات جديدة
A Decade of Data Shows the Value of Isoray's Cesium-131 As
The majority of patients (83%) were treated with a Cesium-131 implant only, while the remainder were treated with external beam or hormone therapy -- or both – added to the Cesium-131 implant in ...
WhatsApp: +86 18221755073
- منتوجات جديدة
Multi-institutional study utilizing surgery + cesium-131 …
Here, we explore the safety and oncologic benefit of cesium 131 brachytherapy combined with salvage surgical resection. Multi-institutional study utilizing surgery + cesium-131 brachytherapy in recurrent head and neck cancer - International Journal of Radiation Oncology, Biology, Physics
WhatsApp: +86 18221755073
- منتوجات جديدة
Feasibility of collagen matrix tiles with cesium …
Locoregional failure is a unique and challenging problem in head and neck cancer with controversy surrounding the use of re-irradiation in the treatment. We aimed to evaluate the dosimetry and technical …
WhatsApp: +86 18221755073
- منتوجات جديدة
Cesium-131 prostate brachytherapy: A single institutional …
Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131 …
WhatsApp: +86 18221755073
- منتوجات جديدة
Cesium-131 Prostate Brachytherapy: A Single …
Ronald M. Benoit Jr., MD, discusses long-term results and urinary outcomes of using cesium-131 brachytherapy in treating 669 men with prostate cancer.
WhatsApp: +86 18221755073
- منتوجات جديدة
C4 Imaging Announces Sirius Positive Signal MRI Marker …
About Isoray Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body.
WhatsApp: +86 18221755073
- منتوجات جديدة
C4 Imaging Announces Sirius Positive Signal MRI Marker
C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray's Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer January 05, 2021 16:55 ET | Source ...
WhatsApp: +86 18221755073
- منتوجات جديدة
The source geometry for Proxcelan 131 Cs seeds. Image …
We aimed to evaluate the dosimetry and technical parameters in utilizing a collagen matrix with embedded Cesium-131 (Cs-131) radioactive isotope seeds as it relates to dose distribution and dose ...
WhatsApp: +86 18221755073
- منتوجات جديدة
IsoRay, Inc.'s Cesium-131 Seeds Proves Successful for Brain …
RICHLAND, WA--(Marketwire - December 11, 2012) - IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the presentation of clinical findings at two medical centers of the successful treatment of brain cancers and tumors using …
WhatsApp: +86 18221755073
- منتوجات جديدة
Isoray's Cesium-131 Spotlighted in Multiple Presentations at …
Isoray is a medical technology company and innovator in seed brachytherapy. The Company is the world's only producer of Cesium-131 brachytherapy, commercially known as Cesium Blu, which is ...
WhatsApp: +86 18221755073
- منتوجات جديدة
Comparison of Three Groups of Patients Having Low Dose …
Cesium-131 is a novel radioisotope with a shorter half-life of 9.7 days and higher energy (30.4KeV) which has been suggested to confer possible clinical …
WhatsApp: +86 18221755073
- منتوجات جديدة
IsoRay Announces World's First Liquid Cesium-131 …
IsoRay, Inc., a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced another milestone -- the treatment of a brain tumor that had ...
WhatsApp: +86 18221755073
- منتوجات جديدة
Feasibility of collagen matrix tiles with cesium-131 …
Feasibility of collagen matrix tiles with cesium-131 brachytherapy for use in the treatment of head and neck cancer. Author links open overlay ... were implanted utilizing 2 cm x 2cm tiles with a 4 mm thickness that have 4 embedded Cs-131 seeds positioned with strands. The cesium seed strands are at a depth of 1 mm within the tile …
WhatsApp: +86 18221755073
- منتوجات جديدة
Frontiers | Permanent Interstitial Cesium-131 Brachytherapy …
The use of Cesium-131 (Cs-131) implants is shown to be feasible in the postoperative setting for recurrent HNC in several small series (8, 9). ... The overall local recurrence rate of 44% in our cohort is comparable to other series utilizing post-operative LDR brachytherapy with other isotopes (24, 30).
WhatsApp: +86 18221755073
- منتوجات جديدة
Long-term outcomes of a prospective randomized trial of …
Purpose. Iodine-125 (125 I) is the most commonly used isotope for prostate brachytherapy (BT).Cesium-131 (131 Cs) has a higher dose rate and shorter dose delivery time resulting in decreased duration of acute urinary morbidity.Long-term data suggest excellent oncologic outcomes; it is not known how outcomes compare. A prospective …
WhatsApp: +86 18221755073
- منتوجات جديدة
Long Term Control Outcomes Utilizing Cesium-131 Prostate …
Cesium-131 (¹³¹Cs) has a higher dose rate and shorter dose delivery time resulting in decreased duration of acute urinary morbidity. Long-term data suggest excellent oncologic outcomes; it is ...
WhatsApp: +86 18221755073
- منتوجات جديدة
Long-term biochemical outcomes using cesium-131 in …
Cesium-131 (131 Cs) has a higher dose rate and shorter dose delivery time, predicting a shorter duration of urinary morbidity. We report our institution's high-volume experience …
WhatsApp: +86 18221755073
- منتوجات جديدة
IsoRay, Inc. Announces Early Success For Young Peruvian Utilizing …
RICHLAND, WA--(Marketwired - October 07, 2014) - IsoRay, Inc. (NYSE MKT: ISR), announced today the excellent results achieved by a young patient who received Cesium-131 seed via a stereotactic implant for inoperable glioblastoma brain tumor.IsoRay is a medical technology company and innovator in seed brachytherapy, …
WhatsApp: +86 18221755073
- منتوجات جديدة
Cesium – Wikipedia
Osittain sulanutta cesiumia lasiampullissa. Pollusiitti on yksi cesiumin tärkeimmistä lähteistä.. Cesium, lausutaan [keesium] [4], on alkuaine, jonka kemiallinen merkki on Cs (lat. caesium) ja järjestysluku 55. Se on pehmeä hopeanhohtoinen alkalimetalli, joka hapettuu nopeasti joutuessaan tekemisiin ilman kanssa. Metallinen cesium reagoi …
WhatsApp: +86 18221755073
- منتوجات جديدة
Thomas Jefferson University Launches Major Head And Neck …
RICHLAND, WA--(Marketwired - May 07, 2015) - IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in brachytherapy and medical isotope applications, today announced the start of a new study of head and neck cancer patients being treated with IsoRay's Cesium-131 internal radiation (brachytherapy) cancer …
WhatsApp: +86 18221755073
- منتوجات جديدة
First clinical implementation of GammaTile permanent brain …
GammaTile cesium-131 (131Cs) permanent brain implant has received Food and Drug Administration (FDA) clearance as a promising treatment for certain brain tumors. Our center was the first institution in the United States after FDA clearance to offer the clinical use of GammaTile brachytherapy outside of a clinical trial. The purpose of …
WhatsApp: +86 18221755073
- منتوجات جديدة
(PDF) Multi-institutional study utilizing surgery + cesium-131
Multi-institutional study utilizing surgery + cesium-131 brachytherapy in recurrent head and neck cancer. Multi-institutional study utilizing surgery + cesium-131 brachytherapy in recurrent head and neck cancer. Pierre Lavertu. 2020, International Journal of Radiation Oncology*Biology*Physics.
WhatsApp: +86 18221755073
- منتوجات جديدة
Use of Cesium-131 radioactive seeds in prostate permanent …
Recently, a new cesium -131 (131 Cs) radioactive seed has been introduced (Iso Ray, Richmond, WA) in the clinical practice for permanent seed implants of early prostate …
WhatsApp: +86 18221755073
- منتوجات جديدة
Perspective Therapeutics Divests Brachytherapy Business
As consideration for the transaction, Perspective will receive an equity interest in GT Medical and will have the right to receive certain cash royalties on net sales of Cesium-131 seeds and GT ...
WhatsApp: +86 18221755073
- منتوجات جديدة
Cesium-131 prostate brachytherapy: A single …
This longitudinal, single-institution study demonstrates that oncologic outcomes are excellent in patients undergoing brachytherapy with 131 Cs, as BFD rates are 97.1%, 94.0%, and 86.2% for low-risk, intermediate …
WhatsApp: +86 18221755073
- منتوجات جديدة
Cesium 131
19 rowsCesium-131 (Cs-131) brachytherapy. Since obtaining FDA approval in 2003, Cs-131 has been used as radioactive permanent seed implants for treatment of prostate, …
WhatsApp: +86 18221755073
- منتوجات جديدة
Cesium-131 prostate brachytherapy: A single institutional …
PSA ≤0.2 ng/dL at 4 years was predictive of 10 year biochemical control: 96.3% vs 70.4%, p < 0.001. Conclusions: The present study demonstrates that prostate brachytherapy with …
WhatsApp: +86 18221755073
- منتوجات جديدة
Cesium-131 permanent seed brachytherapy: Dosimetric evaluation …
Moreover, 131 Cs has a half-life of 9.7 days, which is shorter than 103 Pd and 125 I, delivering the prescribed dose in less time and decreasing the overall exposure to the patient and family.
WhatsApp: +86 18221755073
- منتوجات جديدة
Long Term Control Outcomes Utilizing Cesium-131 Prostate …
131 Cs is a viable alternative isotope for prostate brachytherapy for organ confined disease. Long term biochemical control and survival outcomes, as reported in this series, are excellent and on par with those attained with the use of I-125 or Pd-103.
WhatsApp: +86 18221755073
- منتوجات جديدة
Long-term biochemical outcomes using cesium-131 in …
Iodine-125, the most commonly used isotope, may be associated with long-term urinary consequences. Cesium-131 (131 Cs) has a higher dose rate and shorter dose delivery time, predicting a shorter duration of urinary morbidity. We report our institution's high-volume experience and the most mature data to date on outcomes with 131 Cs prostate …
WhatsApp: +86 18221755073
- منتوجات جديدة
IsoRay, Inc. Announces World's First Liquid Cesium-131
RICHLAND, WA--(Marketwired - June 24, 2014) - IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced another milestone -- the treatment of a brain tumor that had metastasized from esophageal cancer utilizing IsoRay's liquid Cesium …
WhatsApp: +86 18221755073
- منتوجات جديدة
First clinical implementation of GammaTile permanent brain …
Purpose: GammaTile cesium-131 (131 Cs) permanent brain implant has received Food and Drug Administration (FDA) clearance as a promising treatment for certain brain tumors. Our center was the first institution in the United States after FDA clearance to offer the clinical use of GammaTile brachytherapy outside of a clinical trial.
WhatsApp: +86 18221755073
- منتوجات جديدة
IsoRay's Cesium-131 Seeds Proves Successful for Brain …
Statements in this news release about IsoRay's future expectations, including: the advantages of our Cesium-131 seed, the advantages of Cesium-131 in mesh form, whether adoption of Cesium-131 will ...
WhatsApp: +86 18221755073
- منتوجات جديدة
[PDF] Salvage resection plus cesium-131
Cesium-131 brachytherapy resulted in good local control and acceptable rates of symptomatic adverse radiation effects and surgical complications in this heavily pretreated cohort, and it may be a reasonable salvage adjuvant treatment for this patient population. ... R+BT utilizing Cs-131 sources in modular carriers represents a …
WhatsApp: +86 18221755073